Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase IB × defactinib × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Uterine Cervical Neoplasms 1 Phase IB 1 Neoplasms 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Carcinoma, Ovarian Epithelial 1

Interventions

defactinib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07318324 2026-01-06

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting

Phase IB

Data powered by HemOnc (CC BY 4.0) Colophon ⚡